Name: Autonomix Medical, Inc. (AMIX) Financial Statements
Creator: FinSpry

Autonomix Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Autonomix Medical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2025	Mar 2024	Mar 2023	Mar 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	0.18	0.00	0.00	0.00
Gross Profit	-0.18	0.00	0.00	0.00
Operating Expenses
Research & Development	4.73	2.23	0.75	0.00
Selling, General & Administrative	6.86	5.25	1.25	13.59
Operating Expenses	11.59	7.47	1.99	13.59
Operating Income	-11.59	-7.47	-1.99	-13.59
Other Income/Expense
Interest Income	0.35	0.13	0.00	0.00
Interest Expense	0.18	-0.08	0.00	-0.22
Other Income/Expense	0.18	-8.00	0.00	0.31
Income
Income Before Tax	-11.41	-15.43	-1.99	-13.33
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-11.41	-15.43	-1.99	-13.33
Net Income - Continuous Operations	-11.41	-15.43	-1.99	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-11.05	-7.39	-1.99	0.00
EBIT	-11.59	-7.47	-1.99	-13.59
Depreciation & Amortization	0.18	0.08	0.00	0.00
Earnings Per Share
Basic EPS	-6.00	-15.00	-3.00	-124.00
Diluted EPS	-6.00	-15.00	-3.00	-124.00
Basic Shares Outstanding	1.77	1.04	0.60	0.10
Diluted Shares Outstanding	1.77	1.04	0.60	0.10